These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6779835)

  • 41. Side effects of smallpox vaccine.
    FDA Consum; 2004; 38(3):3. PubMed ID: 15218825
    [No Abstract]   [Full Text] [Related]  

  • 42. An in vitro analysis of microbial transmission during EUS-guided FNA and the utility of sterilization agents.
    Sing J; Erickson R; Fader R
    Gastrointest Endosc; 2006 Nov; 64(5):774-9. PubMed ID: 17055873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.
    Earl PL; Americo JL; Wyatt LS; Eller LA; Whitbeck JC; Cohen GH; Eisenberg RJ; Hartmann CJ; Jackson DL; Kulesh DA; Martinez MJ; Miller DM; Mucker EM; Shamblin JD; Zwiers SH; Huggins JW; Jahrling PB; Moss B
    Nature; 2004 Mar; 428(6979):182-5. PubMed ID: 15014500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine.
    Ferrier-Rembert A; Drillien R; Tournier JN; Garin D; Crance JM
    Vaccine; 2008 Mar; 26(14):1794-804. PubMed ID: 18336966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of RP 333, a gene encoding CapD of Rickettsia prowazekii with UDP-glucose 4-epimerase activity.
    Santhanagopalan V; Coker C; Radulovic S
    Gene; 2006 Mar; 369():119-25. PubMed ID: 16386381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infection.
    Jones T
    Curr Opin Mol Ther; 2008 Aug; 10(4):407-17. PubMed ID: 18683106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge.
    Empig C; Kenner JR; Perret-Gentil M; Youree BE; Bell E; Chen A; Gurwith M; Higgins K; Lock M; Rice AD; Schriewer J; Sinangil F; White E; Buller RM; Dermody TS; Isaacs SN; Moyer RW
    Vaccine; 2006 Apr; 24(17):3686-94. PubMed ID: 16430997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunobiological preparations in the 3rd edition of the Czechoslovakian Pharmacopoeia].
    Sagáth J
    Cesk Farm; 1970 Jul; 19(6):225-9. PubMed ID: 5428334
    [No Abstract]   [Full Text] [Related]  

  • 50. Does the effectiveness of influenzal and rickettsial vaccines justify their use?
    POOL BB
    N C Med J; 1948 Jun; 9(6):304-7. PubMed ID: 18864640
    [No Abstract]   [Full Text] [Related]  

  • 51. Allergy to viral and rickettsial vaccines; review of the literature.
    UNTRACHT S; RATNER B
    Ann Allergy; 1950; 8(5):699-707. PubMed ID: 14800166
    [No Abstract]   [Full Text] [Related]  

  • 52. [Principles of optimization and scaling of certain processes in the vaccine production technology. 3. Method of determination of the optimal method of thermal sterilization of sugar solutions].
    Matveev VE; Tarasenko VM; Vorob'ev AA; Smirnov EV
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jan; (1):118-23. PubMed ID: 629124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on the standardization of smallpox vaccine. I. Evaluation of Groth's method.
    Yaoi H; Yamanouchi T
    Yokohama Med Bull; 1967 Aug; 18(4):97-105. PubMed ID: 6081785
    [No Abstract]   [Full Text] [Related]  

  • 54. [Dry smallpox vaccine in Indonesia].
    Ehrengut W
    Dtsch Med Wochenschr; 1971 Jan; 96(3):131. PubMed ID: 5539516
    [No Abstract]   [Full Text] [Related]  

  • 55. [Sterilization and sterile preparations in pharmacy. IV. Sterilization using dry heat].
    Chalabala M; Burelová A
    Cesk Farm; 1967 Feb; 16(2):100-4. PubMed ID: 5343181
    [No Abstract]   [Full Text] [Related]  

  • 56. [Principles for optimizing and guaging several processes in the technology of vaccine production. II. Modeling processes of thermal inactivation of microorganisms].
    Matveev VE; Tarasenko VM; Vorob'ev AA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Dec; (12):77-83. PubMed ID: 341616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potency of liquid calf lymph vaccine.
    Banerjee LN
    Indian Med J; 1967 May; 61(5):124-5. PubMed ID: 6075919
    [No Abstract]   [Full Text] [Related]  

  • 58. [Improvement of the microbiologic quality of vaccine].
    Bugyaki L; Van Kerchove E
    Arch Belg Med Soc; 1976 Oct; 34(8):512-6. PubMed ID: 1028384
    [No Abstract]   [Full Text] [Related]  

  • 59. Vaccine spoilage and vaccine failure.
    Borkow RB
    N Y State J Med; 1975 Feb; 75(3):424-6. PubMed ID: 1055876
    [No Abstract]   [Full Text] [Related]  

  • 60. [Express method of determining the heat resistance of smallpox vaccine].
    Stepanov GM; Lukhminskaia ME; Afanas'eva II
    Vopr Virusol; 1979; (4):431. PubMed ID: 483780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.